Collections
The documents in this collection are a sample of the documents provided by drug maker Roche to a Cochrane group conducting a systematic review of neuraminidase inhibitors (anti-influenza drugs) including oseltamivir (Tamiflu). This Cochrane review is based on full clinical study reports (CSRs) rather than journal articles. CSRs are comprehensive, integrated summaries of trials, typically written according to the ICH E3 guidelines, and submitted by study sponsors to regulatory bodies in support of marketing applications. The detail in CSRs is evident in their length: approximately 100 times the page length of journal publications of trials.
